This article was originally published in The Gray Sheet
Premarket approval application submitted for the Screen automated cervical cancer detection system, the company reports July 6. Autocyte is seeking a primary screening indication for the device, which is intended for use with the Prep liquid sample preparation system ("The Gray Sheet" July 6, p. 14), for which a PMA is pending
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.